Form 4 for GILD Gilead Sciences
Accepted 2024-10-28 00:00:00 ET · period of report 2024-10-25 · accession 0001127602-24-026017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-28 | 2024-10-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | +514 | 21.2K | +2% | — |
| D | 2024-10-28 | 2024-10-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | F - Tax | $89.00 | -242 | 21.0K | -1% | -$21.5K |
| D | 2024-10-28 | 2024-10-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | -514 | 29.0K | -2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-25 | M | A | 514 | — | 21,221 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2024-10-25 | F | D | 242 | $89.00 | 20,979 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-10-25 | M | D | 514 | — | 29,033 | D | — · — to — | 514 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |